Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cally Roper

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|December 11, 2012
A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern TanzaniaRichard J Pearce, Rosalynn Ord, Haprarksh Kaur, et al.
BMJ Global Health|November 7, 2018
Emerging implications of policies on malaria treatment: genetic changes in the <i>Pfmdr-1</i> gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in AfricaLucy C Okell, Lisa Malene Reiter, Lene Sandø Ebbe, et al.
The American Journal of Tropical Medicine and Hygiene|March 30, 2016
Application of Serological Tools and Spatial Analysis to Investigate Malaria Transmission Dynamics in Highland Areas of Southwest UgandaCaroline A Lynch, Jackie Cook, Sarah Nanyunja, et al.
Plos One|September 15, 2010
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistanceJamie T Griffin, Matthew Cairns, Azra C Ghani, et al.
The Journal of Infectious Diseases|June 29, 2007
Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern TanzaniaAnders Enevold, Michael Alifrangis, Juan J Sanchez, et al.
Tropical Medicine & International Health : TM & IH|August 28, 2009
Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, AngolaMichela Menegon, Richard J Pearce, Walter O Inojosa, et al.
JAMA|February 14, 2013
Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysisKassoum Kayentao, Paul Garner, Anne Maria van Eijk, et al.
The Lancet. Infectious Diseases|October 27, 2012
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsAmbrose O Talisuna, Corine Karema, Bernhards Ogutu, et al.
Malaria Journal|March 1, 2023
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in NigeriaAdebanjo J Adegbola, Omotade A Ijarotimi, Akaninyene E Ubom, et al.
Scientific Reports|July 4, 2020
Selective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structureAmy Ibrahim, Ernest Diez Benavente, Debbie Nolder, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|December 11, 2012
A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern TanzaniaRichard J Pearce, Rosalynn Ord, Haprarksh Kaur, et al.
BMJ Global Health|November 7, 2018
Emerging implications of policies on malaria treatment: genetic changes in the <i>Pfmdr-1</i> gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in AfricaLucy C Okell, Lisa Malene Reiter, Lene Sandø Ebbe, et al.
The American Journal of Tropical Medicine and Hygiene|March 30, 2016
Application of Serological Tools and Spatial Analysis to Investigate Malaria Transmission Dynamics in Highland Areas of Southwest UgandaCaroline A Lynch, Jackie Cook, Sarah Nanyunja, et al.
Plos One|September 15, 2010
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistanceJamie T Griffin, Matthew Cairns, Azra C Ghani, et al.
The Journal of Infectious Diseases|June 29, 2007
Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern TanzaniaAnders Enevold, Michael Alifrangis, Juan J Sanchez, et al.
Tropical Medicine & International Health : TM & IH|August 28, 2009
Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, AngolaMichela Menegon, Richard J Pearce, Walter O Inojosa, et al.
JAMA|February 14, 2013
Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysisKassoum Kayentao, Paul Garner, Anne Maria van Eijk, et al.
The Lancet. Infectious Diseases|October 27, 2012
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsAmbrose O Talisuna, Corine Karema, Bernhards Ogutu, et al.
Malaria Journal|March 1, 2023
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in NigeriaAdebanjo J Adegbola, Omotade A Ijarotimi, Akaninyene E Ubom, et al.
Scientific Reports|July 4, 2020
Selective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structureAmy Ibrahim, Ernest Diez Benavente, Debbie Nolder, et al.
Pageof 9